151 related articles for article (PubMed ID: 11518022)
1. Interaction of psychotropic drugs with monoamine oxidase in rat brain.
Gnerre C; Kosel M; Baumann P; Carrupt PA; Testa B
J Pharm Pharmacol; 2001 Aug; 53(8):1125-30. PubMed ID: 11518022
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species.
Egashira T; Takayama F; Yamanaka Y
Jpn J Pharmacol; 1999 Sep; 81(1):115-21. PubMed ID: 10580379
[TBL] [Abstract][Full Text] [Related]
4. Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain.
Egashira T; Takayama F; Yamanaka Y
Gen Pharmacol; 1996 Jul; 27(5):773-8. PubMed ID: 8842678
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
6. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
Youdim MB; Gross A; Finberg JP
Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release.
Kilpatrick IC; Traut M; Heal DJ
Int J Obes Relat Metab Disord; 2001 Oct; 25(10):1454-8. PubMed ID: 11673765
[TBL] [Abstract][Full Text] [Related]
8. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Yáñez M; Fraiz N; Cano E; Orallo F
Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
[TBL] [Abstract][Full Text] [Related]
9. N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors.
Pozdnev VF; Kirkel AZ; Kamyshanskaya NS; Axenova LN; Medvedev AE
J Neural Transm Suppl; 1998; 52():351-5. PubMed ID: 9564638
[TBL] [Abstract][Full Text] [Related]
10. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
[TBL] [Abstract][Full Text] [Related]
11. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria.
Nag M
Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192
[TBL] [Abstract][Full Text] [Related]
12. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).
Leonardi ET; Azmitia EC
Neuropsychopharmacology; 1994 Jul; 10(4):231-8. PubMed ID: 7945733
[TBL] [Abstract][Full Text] [Related]
13. [Effect of various antidepressive agents on brain monoamine oxidase activity].
Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by Zn(2+) of A-form monoamine oxidase in monkey brain mitochondria.
Egashira T; Takayama F; Sakai K
J Pharmacol Sci; 2003 Mar; 91(3):239-45. PubMed ID: 12686747
[TBL] [Abstract][Full Text] [Related]
15. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
Ulus IH; Maher TJ; Wurtman RJ
Biochem Pharmacol; 2000 Jun; 59(12):1611-21. PubMed ID: 10799660
[TBL] [Abstract][Full Text] [Related]
16. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity.
Hauptmann N; Shih JC
Life Sci; 2001 Feb; 68(11):1231-41. PubMed ID: 11233991
[TBL] [Abstract][Full Text] [Related]
17. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
[TBL] [Abstract][Full Text] [Related]
18. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke.
Méndez-Alvarez E; Soto-Otero R; Sánchez-Sellero I; López-Rivadulla Lamas M
Life Sci; 1997; 60(19):1719-27. PubMed ID: 9129127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
